383 related articles for article (PubMed ID: 14555616)
1. A functional genomics approach for the identification of putative tumor suppressor genes: Dickkopf-1 as suppressor of HeLa cell transformation.
Mikheev AM; Mikheeva SA; Liu B; Cohen P; Zarbl H
Carcinogenesis; 2004 Jan; 25(1):47-59. PubMed ID: 14555616
[TBL] [Abstract][Full Text] [Related]
2. The Wnt antagonist DICKKOPF-1 gene is a downstream target of beta-catenin/TCF and is downregulated in human colon cancer.
González-Sancho JM; Aguilera O; García JM; Pendás-Franco N; Peña C; Cal S; García de Herreros A; Bonilla F; Muñoz A
Oncogene; 2005 Feb; 24(6):1098-103. PubMed ID: 15592505
[TBL] [Abstract][Full Text] [Related]
3. Dickkopf-3/REIC functions as a suppressor gene of tumor growth.
Hsieh SY; Hsieh PS; Chiu CT; Chen WY
Oncogene; 2004 Dec; 23(57):9183-9. PubMed ID: 15516983
[TBL] [Abstract][Full Text] [Related]
4. Novel candidate targets of beta-catenin/T-cell factor signaling identified by gene expression profiling of ovarian endometrioid adenocarcinomas.
Schwartz DR; Wu R; Kardia SL; Levin AM; Huang CC; Shedden KA; Kuick R; Misek DE; Hanash SM; Taylor JM; Reed H; Hendrix N; Zhai Y; Fearon ER; Cho KR
Cancer Res; 2003 Jun; 63(11):2913-22. PubMed ID: 12782598
[TBL] [Abstract][Full Text] [Related]
5. Insulin-like growth factor binding protein-related protein 1 (IGFBP-rP1) is a potential tumor suppressor protein for prostate cancer.
Sprenger CC; Damon SE; Hwa V; Rosenfeld RG; Plymate SR
Cancer Res; 1999 May; 59(10):2370-5. PubMed ID: 10344746
[TBL] [Abstract][Full Text] [Related]
6. Isolation of a novel human gene, APCDD1, as a direct target of the beta-Catenin/T-cell factor 4 complex with probable involvement in colorectal carcinogenesis.
Takahashi M; Fujita M; Furukawa Y; Hamamoto R; Shimokawa T; Miwa N; Ogawa M; Nakamura Y
Cancer Res; 2002 Oct; 62(20):5651-6. PubMed ID: 12384519
[TBL] [Abstract][Full Text] [Related]
7. Strong suppression of tumor growth by insulin-like growth factor-binding protein-related protein 1/tumor-derived cell adhesion factor/mac25.
Sato Y; Chen Z; Miyazaki K
Cancer Sci; 2007 Jul; 98(7):1055-63. PubMed ID: 17465992
[TBL] [Abstract][Full Text] [Related]
8. Signaling cross-talk between IGF-binding protein-3 and transforming growth factor-(beta) in mesenchymal chondroprogenitor cell growth.
O'Rear L; Longobardi L; Torello M; Law BK; Moses HL; Chiarelli F; Spagnoli A
J Mol Endocrinol; 2005 Jun; 34(3):723-37. PubMed ID: 15956343
[TBL] [Abstract][Full Text] [Related]
9. Stabilized beta-catenin immortalizes colonic epithelial cells.
Wagenaar RA; Crawford HC; Matrisian LM
Cancer Res; 2001 Mar; 61(5):2097-104. PubMed ID: 11280772
[TBL] [Abstract][Full Text] [Related]
10. Activation of tumor suppressor genes in nontumorigenic revertants of the HeLa cervical carcinoma cell line.
Boylan MO; Athanassiou M; Houle B; Wang Y; Zarbl H
Cell Growth Differ; 1996 Jun; 7(6):725-35. PubMed ID: 8780886
[TBL] [Abstract][Full Text] [Related]
11. Expression of Dickkopf genes is strongly reduced in malignant melanoma.
Kuphal S; Lodermeyer S; Bataille F; Schuierer M; Hoang BH; Bosserhoff AK
Oncogene; 2006 Aug; 25(36):5027-36. PubMed ID: 16568085
[TBL] [Abstract][Full Text] [Related]
12. Defining the critical gene expression changes associated with expression and suppression of the tumorigenic and metastatic phenotype in Ha-ras-transformed cloned rat embryo fibroblast cells.
Su ZZ; Austin VN; Zimmer SG; Fisher PB
Oncogene; 1993 May; 8(5):1211-9. PubMed ID: 8479744
[TBL] [Abstract][Full Text] [Related]
13. Activation of Wnt/beta-catenin/Tcf signaling in mouse skin carcinogenesis.
Bhatia N; Spiegelman VS
Mol Carcinog; 2005 Apr; 42(4):213-21. PubMed ID: 15765534
[TBL] [Abstract][Full Text] [Related]
14. Dickkopf-1 mediated tumor suppression in human breast carcinoma cells.
Mikheev AM; Mikheeva SA; Maxwell JP; Rivo JV; Rostomily R; Swisshelm K; Zarbl H
Breast Cancer Res Treat; 2008 Nov; 112(2):263-73. PubMed ID: 18157634
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of inhibition of differentiation-1 via activation of activating transcription factor 3 and Smad regulates REIC/Dickkopf-3-induced apoptosis.
Kashiwakura Y; Ochiai K; Watanabe M; Abarzua F; Sakaguchi M; Takaoka M; Tanimoto R; Nasu Y; Huh NH; Kumon H
Cancer Res; 2008 Oct; 68(20):8333-41. PubMed ID: 18922905
[TBL] [Abstract][Full Text] [Related]
16. Suppression of v-sis-dependent transformation by the transcription factor, Egr-1.
Huang RP; Darland T; Okamura D; Mercola D; Adamson ED
Oncogene; 1994 May; 9(5):1367-77. PubMed ID: 8152797
[TBL] [Abstract][Full Text] [Related]
17. IGF-independent effects of IGFBP-2 on the human breast cancer cell line Hs578T.
Frommer KW; Reichenmiller K; Schutt BS; Hoeflich A; Ranke MB; Dodt G; Elmlinger MW
J Mol Endocrinol; 2006 Aug; 37(1):13-23. PubMed ID: 16901920
[TBL] [Abstract][Full Text] [Related]
18. SKI activates Wnt/beta-catenin signaling in human melanoma.
Chen D; Xu W; Bales E; Colmenares C; Conacci-Sorrell M; Ishii S; Stavnezer E; Campisi J; Fisher DE; Ben-Ze'ev A; Medrano EE
Cancer Res; 2003 Oct; 63(20):6626-34. PubMed ID: 14583455
[TBL] [Abstract][Full Text] [Related]
19. Nuclear factor-kappaB is an important modulator of the altered gene expression profile and malignant phenotype in squamous cell carcinoma.
Loercher A; Lee TL; Ricker JL; Howard A; Geoghegen J; Chen Z; Sunwoo JB; Sitcheran R; Chuang EY; Mitchell JB; Baldwin AS; Van Waes C
Cancer Res; 2004 Sep; 64(18):6511-23. PubMed ID: 15374962
[TBL] [Abstract][Full Text] [Related]
20. Decreased tumorigenicity of c-Myc-transformed fibroblasts expressing active USF2.
Choe C; Chen N; Sawadogo M
Exp Cell Res; 2005 Jan; 302(1):1-10. PubMed ID: 15541720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
